Origent is dedicated to revolutionizing drug discovery and clinical development by managing and reducing drug development risks through better foresight. We are experts in the development and application of predictive models designed to anticipate and predict disease progression. Our core focus is directed toward creating and implementing novel methodologies that extend the utility of machine learning models to uncover deeper levels of insight and gain clearer understanding and knowledge from clinical trial data. This focus allows us to accelerate the process of drug efficacy evaluation and discovery by: ● Conducting smaller, faster clinical trials, thus reducing costs and risks ● Generating quantifiable efficacy data from trials that lack control arms ● Spotting failing projects sooner to prioritize resources for the most promising therapies ● Identifying patients and patient subgroups that respond to therapies in comparison to how their symptoms likely would have progressed